Searchable abstracts of presentations at key conferences in endocrinology

ea0063p650 | Interdisciplinary Endocrinology 1 | ECE2019

Helicobacter pylori infection in patients with celiac disease

Jazia Elhem Ben , Mrabet Soumaya , Akkari Imen , Jemni Imen

Different studies indicated the possible association between lymphocytic gastritis and both celiac disease and Helicobacter pylori infection, although this evidence is not consistently accepted.Objective: We aimed to determine whether Helicobacter pylori infection and celiac disease were associated among patients undergoing upper gastrointestinal endoscopy.Methods: Between January 2016 and June 2017, patients over...

ea0063p636 | Interdisciplinary Endocrinology 1 | ECE2019

Helicobacter pylori infection in patients with celiac disease

Mrabet Soumaya , Jemni Imen , Akkari Imen , Jazia Elhem Ben

Introduction: Different studies indicated the possible association between celiac disease and Helicobacter pylori (HP) infection, although this evidence is not consistently accepted. The aim of our study was to determine whether HP infection and celiac disease were associated among patients undergoing upper gastrointestinal endoscopy.Methods: Between January 2017 and June 2018, patients undergoing upper gastrointestinal endoscopy with both gastric and du...

ea0063ep73 | Interdisciplinary endocrinology | ECE2019

Steatosis in chronic hepatitis C: prevalence and therapeutic impact

Mrabet Soumaya , Jemni Imen , Akkari Imen , Jazia Elhem Ben

Introduction: Steatosis has become an important issue in hepatitis C, due to the injury it can cause in a chronically ill liver. In chronic hepatitis C patients, the prevalence of steatosis ranges from 40–86%. Steatosis was significantly associated with the lack of response using PEG-IFN and ribavirin. The aim of our study was to determine the prevalence of hepatic steatosis in chronic hepatitis C and determine its impact on the therapeutic response using new direct antiv...

ea0063p883 | Diabetes, Obesity and Metabolism 3 | ECE2019

Impact of the overweight and fatty liver in chronic hepatitis B treatment

Kallel Roua , Akkari Imen , Mrabet Soumaya , Jemni Imen , Jezia Elhem Ben

Background: More than 1.9 billion people in the world are suffering from overweight. Damages can be caused to the liver such as fatty liver or even Cirrhosis. The aims of this study are to determine the prevalence and the impact of steatosis and overweight on therapeutic response in chronic hepatitis B.Methods: This is a descriptive transversal study enrolled from 01/2010 to 09/2018. All patients with chronic hepatitis B investigated by liver biopsy were...